Form 8-K Omega Therapeutics, Inc. For: Apr 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Omega Therapeutics (OMGA) Announces CFO Termination
April 16, 2024 4:22 PM EDTOn April 10, 2024, Omega Therapeutics, Inc. (NASDAQ: OMGA) and Joshua Reed, the Companys Chief Financial Officer, agreed to terminate his employment effective as of May 31, 2024 (the Effective Date). In connection with the termination, Mr. Reed will be entitled to receive the severance payments and... More
